Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Health Economic Evaluation of Fecal Molecular Susceptibility-guided Therapy for Helicobacter Pylori Infection Rescue Treatment: Multicenter Randomized Controlled Study

NCT07405697 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07405697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Health Economic Evaluation of Fecal Molecular Susceptibility-guided Therapy for Helicobacter Pylori Infection Rescue Treatment: Multicenter Randomized Controlled Study
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
December 31, 2028
Enrollment
290 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection